Deutsche Bank’s Rosetta Genomics ROSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-2
Closed – – 5835
2017
Q4
$0 Hold
2
– – ﹤0.01% 5351
2017
Q3
$0 Buy
+2
New +$4 ﹤0.01% 5332
2017
Q1
– Hold
0
– – – 5286
2016
Q4
– Hold
0
– – – 5224
2016
Q3
– Hold
0
– – – 5441
2016
Q2
– Hold
0
– – – 5494

Other funds holding ROSG

Deutsche Bank's ROSG Position: Q1 2018 in Review

Deutsche Bank sold out of Rosetta Genomics (ROSG) in Q1 2018, closing a stake of 2 shares.

Deutsche Bank first reported a position in ROSG in Q3 2017 and held it in 2 quarters. The position peaked at $0 in Q4 2017. 8 funds tracked by Wall St. Rank hold ROSG as of Q1 2018.

  • Deutsche Bank reported no remaining Rosetta Genomics position as of Q1 2018 after selling out during the quarter.
  • Deutsche Bank sold 2 Rosetta Genomics shares in Q1 2018.
  • Deutsche Bank first reported a position in Rosetta Genomics in Q3 2017 and held it in 2 quarters.
  • Deutsche Bank's Rosetta Genomics position peaked at $0 in Q4 2017.
  • 8 funds tracked by Wall St. Rank held Rosetta Genomics as of Q1 2018.

Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.